rs752516966

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4BP6_Very_StrongBS2

The ENST00000370818.8(GPC3):ā€‹c.648G>Cā€‹(p.Met216Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000736 in 1,209,855 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 30 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…). Another nucleotide change resulting in same amino acid change has been previously reported as Uncertain significancein ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M216V) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.000054 ( 0 hom., 0 hem., cov: 23)
Exomes š‘“: 0.000076 ( 0 hom. 30 hem. )

Consequence

GPC3
ENST00000370818.8 missense

Scores

2
4
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.19
Variant links:
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.29042616).
BP6
Variant X-133753866-C-G is Benign according to our data. Variant chrX-133753866-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 239944.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAdExome4 at 30 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GPC3NM_004484.4 linkuse as main transcriptc.648G>C p.Met216Ile missense_variant 3/8 ENST00000370818.8 NP_004475.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GPC3ENST00000370818.8 linkuse as main transcriptc.648G>C p.Met216Ile missense_variant 3/81 NM_004484.4 ENSP00000359854 P1P51654-1

Frequencies

GnomAD3 genomes
AF:
0.0000537
AC:
6
AN:
111817
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
33987
show subpopulations
Gnomad AFR
AF:
0.0000325
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000940
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000659
AC:
12
AN:
182030
Hom.:
0
AF XY:
0.0000594
AC XY:
4
AN XY:
67310
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000146
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000994
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000756
AC:
83
AN:
1098038
Hom.:
0
Cov.:
33
AF XY:
0.0000826
AC XY:
30
AN XY:
363400
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000199
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000879
Gnomad4 OTH exome
AF:
0.0000434
GnomAD4 genome
AF:
0.0000537
AC:
6
AN:
111817
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
33987
show subpopulations
Gnomad4 AFR
AF:
0.0000325
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000940
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000868
Hom.:
1
Bravo
AF:
0.0000756
ExAC
AF:
0.0000577
AC:
7
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 27, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxJul 17, 2020- -
Wilms tumor 1 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 20, 2023- -
Simpson-Golabi-Behmel syndrome type 1;CN033288:Wilms tumor 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMar 04, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.35
T;.;.
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.87
D;D;D
M_CAP
Pathogenic
0.46
D
MetaRNN
Benign
0.29
T;T;T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
1.7
L;L;.
MutationTaster
Benign
0.87
D;D;D
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-1.5
N;N;.
REVEL
Benign
0.14
Sift
Benign
0.14
T;T;.
Sift4G
Benign
0.15
T;T;T
Polyphen
0.069
B;.;.
Vest4
0.26
MutPred
0.60
Gain of catalytic residue at M216 (P = 0.0185);Gain of catalytic residue at M216 (P = 0.0185);.;
MVP
0.52
MPC
0.38
ClinPred
0.058
T
GERP RS
5.8
Varity_R
0.60
gMVP
0.78

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs752516966; hg19: chrX-132887893; API